Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP

Biochemistry

Volumn 52, Issue 36, 2013, Pages 6151-6159

  Shadrick, William R ^a,b   Mukherjee, Sourav ^a   Hanson, Alicia M ^a   Sweeney, Noreena L ^a   Frick, David N ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ATP-BINDING SITE; AURINTRICARBOXYLIC ACIDS; DIRECT INTERACTIONS; HEPATITIS C VIRUS; MICRO-CALORIMETRY; THERMODYNAMIC PARAMETER; VIRUS REPLICATION;

AMINO ACIDS; ENZYMES; NUCLEIC ACIDS; THERMODYNAMICS; VIRUSES;

BIOMOLECULES;

ADENOSINE TRIPHOSPHATE; AURINTRICARBOXYLIC ACID; HELICASE; MONTIRELIN; NUCLEIC ACID;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CATALYSIS; DISSOCIATION CONSTANT; DNA BINDING; ENTHALPY; ENTROPY; ENZYME BINDING; HEPATITIS C VIRUS; HYDROLYSIS; MICROCALORIMETRY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THERMODYNAMICS;

ADENOSINE TRIPHOSPHATE; AMINO ACID SUBSTITUTION; AURINTRICARBOXYLIC ACID; CALORIMETRY, DIFFERENTIAL SCANNING; DNA; HEPACIVIRUS; MODELS, MOLECULAR; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84884253048     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi4006495     Document Type: Article

References (47)

1. Bolton, E. E., Wang, Y., Thiessen, P. A., and Bryant, S. H. (2008) PubChem: integrated platform of small molecules and biological activities Annu. Rep. Comput. Chem. 4, 217-241
2. Blumenthal, T. and Landers, T. A. (1973) The inhibition of nucleic acid-binding proteins by aurintricarboxylic acid Biochem. Biophys. Res. Commun. 55, 680-688
3. Ghosh, U., Giri, K., and Bhattacharyya, N. P. (2009) Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase Spectrochim. Acta, Part A 74, 1145-1151
4. Gonzalez, R. G., Blackburn, B. J., and Schleich, T. (1979) Fractionation and structural elucidation of the active components of aurintricarboxylic acid, a potent inhibitor of protein nucleic acid interactions Biochim. Biophys. Acta 562, 534-545
5. Cushman, M., Wang, P., Schols, D., and De Clercq, E. (1992) Structure investigation and anti-HIV activities of high-molecular weight ATA polymers J. Org. Chem. 57, 7241-7248
6. Skidmore, A. F. and Beebee, T. J. (1989) Characterization and use of the potent ribonuclease inhibitor aurintricarboxylic acid for the isolation of RNA from animal tissues Biochem. J. 263, 73-80
7. Gonzalez, R. G., Haxo, R. S., and Schleich, T. (1980) Mechanism of action of polymeric aurintricarboxylic acid, a potent inhibitor of protein - nucleic acid interactions Biochemistry 19, 4299-4303
8. Tan, G. S., Chiu, C. H., Garchow, B. G., Metzler, D., Diamond, S. L., and Kiriakidou, M. (2012) Small Molecule Inhibition of RISC Loading ACS Chem. Biol. 7, 403-410
9. Dorjsuren, D., Kim, D., Maloney, D. J., Wilson, D. M., and Simeonov, A. (2011) Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity Nucleic Acids Res. 39, e11
10. Chen, Y., Bopda-Waffo, A., Basu, A., Krishnan, R., Silberstein, E., Taylor, D. R., Talele, T. T., Arora, P., and Kaushik-Basu, N. (2009) Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor Antivir. Chem. Chemother. 20, 19-36
11. Mukherjee, S., Hanson, A. M., Shadrick, W. R., Ndjomou, J., Sweeney, N. L., Hernandez, J. J., Bartczak, D., Li, K., Frankowski, K. J., Heck, J. A., Arnold, L. A., Schoenen, F. J., and Frick, D. N. (2012) Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays Nucleic Acids Res. 40, 8607-8621
12. Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., Zhou, Z., Han, L., Karapetyan, K., Dracheva, S., Shoemaker, B. A., Bolton, E., Gindulyte, A., and Bryant, S. H. (2012) PubChem's BioAssay Database Nucleic Acids Res. 40, D400-D412
13. Hashem, A. M., Flaman, A. S., Farnsworth, A., Brown, E. G., Van Domselaar, G., He, R., and Li, X. (2009) Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases PLoS One 4, e8350
14. Benchokroun, Y., Couprie, J., and Larsen, A. K. (1995) Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells Biochem. Pharmacol. 49, 305-313
15. Rui, H., Xu, J., Mehta, S., Fang, H., Williams, J., Dong, F., and Grimley, P. M. (1998) Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid J. Biol. Chem. 273, 28-32
16. McCune, S. A., Foe, L. G., Kemp, R. G., and Jurin, R. R. (1989) Aurintricarboxylic acid is a potent inhibitor of phosphofructokinase Biochem. J. 259, 925-927
17. Tsi, C. J., Chao, Y., Chen, C. W., and Lin, W. W. (2002) Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition Mol. Pharmacol. 62, 90-101
18. Chen, C. W., Chao, Y., Chang, Y. H., Hsu, M. J., and Lin, W. W. (2002) Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid Br. J. Pharmacol. 137, 1011-1020
19. Tai, C. L., Chi, W. K., Chen, D. S., and Hwang, L. H. (1996) The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3) J. Virol. 70, 8477-8484
20. Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., Burroughs, M., Brass, C. A., Albrecht, J. K., and Esteban, R. (2011) Boceprevir for previously treated chronic HCV genotype 1 infection N. Engl. J. Med. 364, 1207-1217
21. Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., Ferenci, P., Nevens, F., Mullhaupt, B., Pockros, P., Terg, R., Shouval, D., van Hoek, B., Weiland, O., Van Heeswijk, R., De Meyer, S., Luo, D., Boogaerts, G., Polo, R., Picchio, G., and Beumont, M. (2011) Telaprevir for retreatment of HCV infection N. Engl. J. Med. 364, 2417-2428
22. Belon, C. A. and Frick, D. N. (2011) in Hepatitis C: Antiviral Drug Discovery and Development (He, Y. and Tan, S. L., Eds.) pp 237-256, Caister Academic Press, Norfolk, U. K.
23. Frick, D. N., Rypma, R. S., Lam, A. M., and Gu, B. (2004) The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently J. Biol. Chem. 279, 1269-1280
24. Beran, R. K. and Pyle, A. M. (2008) Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase J. Biol. Chem. 283, 29929-29937
25. Ndjomou, J., Kolli, R., Mukherjee, S., Shadrick, W. R., Hanson, A. M., Sweeney, N. L., Bartczak, D., Li, K., Frankowski, K. J., Schoenen, F. J., and Frick, D. N. (2012) Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation Antiviral Res. 96, 245-255
26. Kim, J. L., Morgenstern, K. A., Griffith, J. P., Dwyer, M. D., Thomson, J. A., Murcko, M. A., Lin, C., and Caron, P. R. (1998) Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding Structure 6, 89-100
27. Levin, M. K., Gurjar, M., and Patel, S. S. (2005) A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase Nat. Struct. Mol. Biol. 12, 429-435
28. Levin, M. K., Gurjar, M. M., and Patel, S. S. (2003) ATP binding modulates the nucleic acid affinity of hepatitis C virus helicase J. Biol. Chem. 278, 23311-23316
29. Gu, M. and Rice, C. M. (2010) Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism Proc. Natl. Acad. Sci. U. S. A. 107, 521-528
30. Chen, C. S., Chiou, C. T., Chen, G. S., Chen, S. C., Hu, C. Y., Chi, W. K., Chu, Y. D., Hwang, L. H., Chen, P. J., Chen, D. S., Liaw, S. H., and Chern, J. W. (2009) Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase J. Med. Chem. 52, 2716-2723
31. Belon, C. A., High, Y. D., Lin, T. I., Pauwels, F., and Frick, D. N. (2010) Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor Biochemistry 49, 1822-1832
32. Frick, D. N., Banik, S., and Rypma, R. S. (2007) Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: magnesium provides a bridge for ATP to fuel unwinding J. Mol. Biol. 365, 1017-1032
33. Frick, D. N., Rypma, R. S., Lam, A. M., and Frenz, C. M. (2004) Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations Nucleic Acids Res. 32, 5519-5528
34. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108
35. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera - a visualization system for exploratory research and analysis J. Comput. Chem. 25, 1605-1612
36. Moustakas, D. T., Lang, P. T., Pegg, S., Pettersen, E., Kuntz, I. D., Brooijmans, N., and Rizzo, R. C. (2006) Development and validation of a modular, extensible docking program: DOCK 5 J. Comput.-Aided Mol. Des. 20, 601-619
37. Frick, D. N., Banik, S., and Rypma, R. S. (2006) Modulation of the hepatitis C virus NS3 helicase activity by divalent metal cations Hepatology 44, 342A-342A
38. Suzich, J. A., Tamura, J. K., Palmer-Hill, F., Warrener, P., Grakoui, A., Rice, C. M., Feinstone, S. M., and Collett, M. S. (1993) Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes J. Virol. 67, 6152-6158
39. Lam, A. M., Keeney, D., Eckert, P. Q., and Frick, D. N. (2003) Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties J. Virol. 77, 3950-3961
40. Turnbull, W. B. and Daranas, A. H. (2003) On the value of c: can low affinity systems be studied by isothermal titration calorimetry? J. Am. Chem. Soc. 125, 14859-14866
41. Preugschat, F., Averett, D. R., Clarke, B. E., and Porter, D. J. (1996) A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain J. Biol. Chem. 271, 24449-24457
42. Yao, N., Hesson, T., Cable, M., Hong, Z., Kwong, A. D., Le, H. V., and Weber, P. C. (1997) Structure of the hepatitis C virus RNA helicase domain Nat. Struct. Biol. 4, 463-467
43. Cho, H. S., Ha, N. C., Kang, L. W., Chung, K. M., Back, S. H., Jang, S. K., and Oh, B. H. (1998) Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA J. Biol. Chem. 273, 15045-15052
44. Sikora, B., Chen, Y., Lichti, C. F., Harrison, M. K., Jennings, T. A., Tang, Y., Tackett, A. J., Jordan, J. B., Sakon, J., Cameron, C. E., and Raney, K. D. (2008) Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro J. Biol. Chem. 283, 11516-11525
45. Jennings, T. A., Mackintosh, S. G., Harrison, M. K., Sikora, D., Sikora, B., Dave, B., Tackett, A. J., Cameron, C. E., and Raney, K. D. (2009) NS3 helicase from the hepatitis C Virus can function as a monomer or oligomer depending on enzyme and substrate concentrations J. Biol. Chem. 284, 4806-4814
46. Li, K., Frankowski, K. J., Belon, C. A., Neuenswander, B., Ndjomou, J., Hanson, A. M., Shanahan, M. A., Schoenen, F. J., Blagg, B. S., Aube, J., and Frick, D. N. (2012) Optimization of Potent Hepatitis C Virus NS3 Helicase Inhibitors Isolated from the Yellow Dyes Thioflavine S and Primuline J. Med. Chem. 55, 3319-3330
47. Cushman, M., Wang, P. L., Chang, S. H., Wild, C., De Clercq, E., Schols, D., Goldman, M. E., and Bowen, J. A. (1991) Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight J. Med. Chem. 34, 329-337